Adalimumab

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13096 publications

Evaluating Random-Access CLIA for Anti-TNF Drug Monitoring: a Comparison with Traditional ELISA.

Evaluating Random-Access CLIA for Anti-TNF Drug Monitoring: a Comparison with Traditional ELISA.

Journal: Clinical laboratory

Published: April 14, 2026

Finding Clarity in the Battle With Crohn's Disease.

Finding Clarity in the Battle With Crohn's Disease.

Journal: IEEE pulse

Published: April 14, 2026

Vogt-Koyanagi-Harada disease recurrence after laser treatment: A case report.

Vogt-Koyanagi-Harada disease recurrence after laser treatment: A case report.

Journal: The Journal of international medical research

Published: April 12, 2026

Initiation and Continuation of Adalimumab with Methotrexate for Juvenile Idiopathic Arthritis-Associated Uveitis: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Initiation and Continuation of Adalimumab with Methotrexate for Juvenile Idiopathic Arthritis-Associated Uveitis: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Journal: Ocular immunology and inflammation

Published: April 07, 2026

The effect of hypochlorous acid on urine color among pediatric ulcerative colitis patients treated with mesalamine.

The effect of hypochlorous acid on urine color among pediatric ulcerative colitis patients treated with mesalamine.

Journal: Minerva gastroenterology

Published: April 02, 2026

Considerations for infection risks identified in target safety review.

Considerations for infection risks identified in target safety review.

Journal: The Journal of toxicological sciences

Published: April 01, 2026

Personalised treatment in biologically naive patients with Crohn's disease: a systematic review of the last 10 years.

Personalised treatment in biologically naive patients with Crohn's disease: a systematic review of the last 10 years.

Journal: Scandinavian journal of gastroenterology

Published: March 28, 2026

SMI-guided deep remission and TCM-assisted biologic De-intensification in rheumatoid arthritis: Yiqi-Jianpi-Tongluo combined with TNF-α inhibitors.

SMI-guided deep remission and TCM-assisted biologic De-intensification in rheumatoid arthritis: Yiqi-Jianpi-Tongluo combined with TNF-α inhibitors.

Journal: Pakistan journal of pharmaceutical sciences

Published: March 25, 2026

Performance evaluation of an adalimumab biosimilar autoinjector and its reference device: comparative use human factors study in patients with rheumatoid arthritis and juvenile idiopathic arthritis.

Performance evaluation of an adalimumab biosimilar autoinjector and its reference device: comparative use human factors study in patients with rheumatoid arthritis and juvenile idiopathic arthritis.

Journal: Drug delivery

Published: March 24, 2026

Prevalence of Latent and Active Tuberculosis Infection in Inflammatory Bowel Disease Patients Who Received Biological Treatment.

Prevalence of Latent and Active Tuberculosis Infection in Inflammatory Bowel Disease Patients Who Received Biological Treatment.

Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

Published: March 18, 2026

Long-Term Efficacy and Safety of Adalimumab in Pediatric Non-Infectious Uveitis: Including Weekly Dosing Escalation in Refractory Cases.

Long-Term Efficacy and Safety of Adalimumab in Pediatric Non-Infectious Uveitis: Including Weekly Dosing Escalation in Refractory Cases.

Journal: Ocular immunology and inflammation

Published: March 18, 2026

Comparative risk of psoriatic arthritis in psoriasis patients on immunomodulators.

Comparative risk of psoriatic arthritis in psoriasis patients on immunomodulators.

Journal: Proceedings (Baylor University. Medical Center)

Published: March 16, 2026

Showing 1-12 of 13,096

Last Updated: 04/28/2026